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Purpose: The effects of a carbon ion beam and X-rays on human pancreatic cancer stem-like cells were
examined from the point of view of clonogenic survival and DNA repair.
Materials and methods: Human pancreatic cancer stem-like cells were treated with and without carbon
ion and X-ray irradiation, and then colony, spheroid and tumor formation assays as well as cH2AX foci
formation assay were performed.
Results: The relative biological effectiveness (RBE) values of a carbon ion beam relative to X-ray for the
MIA PaCa-2 and BxPc-3 cells at the D10 values were 1.85–2.10. The ability for colony, spheroid formation,
and tumorigenicity from cancer stem-like CD44+/CD24+ cells is signiﬁcantly higher than that from non-
cancer stem-like CD44/CD24cells. FACS data showed that CD44+/CD24+ cells were more highly
enriched after X-rays compared to carbon ion irradiation at isoeffective doses. The RBE values for the car-
bon ion beam relative to X-ray at the D10 levels for CD44+/CD24+ cells were 2.0–2.19. The number of
cH2AX foci in CD44/CD24 cells was higher than that of CD44+/CD24+ cells after irradiation with either
X-ray or carbon ion beam. The number of cH2AX foci in CD44+/CD24+ cells was almost the same in the
early time, but it persists signiﬁcantly longer in carbon ion beam irradiated cells compared to X-rays.
Conclusions: Carbon ion beam has superior potential to kill pancreatic cancer stem cell-like cells, and pro-
longed induction of DNA damage might be one of the pivotal mechanisms of its high radiobiological
effects compared to X-rays.
 2012 Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.
Radiotherapy and Oncology 105 (2012) 258–265Pancreatic cancer has a dismal prognosis, and it has become the
ﬁfth leading cause of cancer death in the United States as well as in
Japan [1,2]. Pancreatic cancer is usually diagnosed in an advanced
state, therefore only about 15% of patients are surgically resectable,
and the 5-year survival rate is less than 6%. In the case of locally
advanced unresectable cancer, the prognosis is very poor [3].
Cancer stem cells have been identiﬁed in several tumor types,
such as colon, gastric and liver cancer [4]. CD44+CD24+ESA+ and
CD133+ have been reported as markers for identifying pancreatic
cancer stem cells [5,6]. Cancer stem cells have the ability to gener-
ate tumors that recapitulate the original tumor when xenotrans-
planted into animals, whereas the remaining non-cancer stem
cells tumor bulk most often cannot [7]. Cancer stem cells have been
shown to be resistant to conventional chemotherapy and radiation
therapy [8] and are thought to be closely related to metastasis andResearch Program, Research
ute of Radiological Sciences,
er CC BY-NC-ND license.recurrence [9]. Therefore, eradication of this small subgroup of can-
cer stem cells in the bulk tumor directly affects prognosis [10].
Radiotherapy is widely used for cancer treatment and relies on
ionizing radiation (IR)-induced DNA damage, especially the induc-
tion of DNA double strand breaks (DSBs). Phosphorylation of H2AX
is a sensitive marker for observation of radiation-induced DSB
[11]. The number of cH2AX foci formed after radiation is closely re-
lated with the number of DSB formed, and their dephosphorylation
has been correlated with repair of DSB [12]. Therefore, the rate of
disappearance of radiation-induced cH2AX foci correlates directly
with the rate of DNA repair at low levels of DNAdamage [13]. Slowly
repaired or unrepaired DSB may be responsible for cell death.
The heavy ion medical accelerator in Chiba (HIMAC) at the Na-
tional Institute of Radiologic Science (NIRS) has treated more than
6000 patients with various types of cancer, and achieved promising
results to date [14,15]. Carbon-ion radiotherapy has several poten-
tial advantages over photon therapy such as the high relative bio-
logical effectiveness, the lack of the oxygen effect, and less cell
cycle-related radiosensitivity [5,6]. In addition, several studies
have shown that DSBs generated by heavy ion irradiation are re-
paired with slow kinetics compared to X or c-ray induced DSBs
K. Oonishi et al. / Radiotherapy and Oncology 105 (2012) 258–265 259[16]. Recently, we have reported that a carbon ion beam has a
marked effect on colon cancer stem cells, which are resistant to
photon beams [17]. However, it has not yet been investigated
how and why carbon ion beam is superior to destroy cancer
stem-like cells, especially from the point of view of DNA damage
and repair.
In the present study, we sought to investigate the distinct ef-
fects of carbon ion beam and X-ray irradiation on putative pancre-
atic cancer stem cells from the point of view of clonogenic survival
and DNA repair. To the best of our knowledge, this is the ﬁrst to
show why high LET heavy ion radiation has an advantage in
targeting pancreatic cancer stem-like cells compared to conven-
tional X-ray irradiation.Materials and methods
Cell lines
Human pancreatic cancer cell lines, MIA PaCa-2 and BxPc-3,
were purchased from American Type Culture Collection (Manassas,
VA). Unsorted cells were cultured in Royal Park Memorial Institute
(RPMI) supplemented with 10% heat-inactivated fetal calf serum
(Beit-HaEmek, Israel), 100 U/mL penicillin and 100 lg/mL strepto-
mycin (Invitrogen) in a 37 C with 5% CO2-in-air. The medium was
changed every other day. Cancer stem-like and non-cancer stem-
like cells isolated from MIA PaCa-2 and BxPc-3 cells were cultured
with serum-free culture medium (DMEM/F-12 supplemented with
bFGF, EGF and B27).Colony and spheroid formation assays
Clonogenicity and spheroid formation ability assay for CD44+/
CD24+ and CD44/CD24 cells sorted from MIA PaCa-2 and BxPc-
3 cells were performed as described previously [17]. The data are
presented as percentage of the wells that contained spheres.0
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Fig. 1. Colony, spheroid, and tumor formation of cancer stem-like and non-cancer stem
delivered from MIA PaCa-2 (A) and BxPc-3 cells (B) after being in culture for 1–2 week. Re
to colony or sphere formed from CD44+/CD24+ cells.In vivo tumorigenic assay
Tumor formation assay for CD44+/CD24+ and CD44/CD24 cells
was also performed as described previously [17]. The animals were
observed at least 12 weeks, and tumorigenicity was determined
when tumor nodules were identiﬁed on their body surfaces. All
experiments involving the use of animals were performed in
accordance with NIRS institutional animal welfare guidelines.
NOD/SCIDmice (Charles River Laboratories, Yokohama, Japan)were
maintained under deﬁned conditions at the NIRS animal facility.Irradiation
Cells were irradiated with carbon-ion beams (accelerated by the
HIMAC). Brieﬂy, the initial energy of the carbon-ion beams was
290 MeV/n, 50 KeV/lm, 6 cm Spread-Out Bragg Peak (SOBP). As a
reference, cells were also irradiated with conventional 200 kVp
X-ray (Pantac HF-320S, Shimadzu Co., Tokyo).FACS analysis
FACS analysis for the cells irradiated with X-ray or carbon ion
was performed as described previously [17].cH2AX immunoﬂuorescence assay
Cultured cells grown on plastic chamber slides (Lab-Tek Nunc,
USA) were ﬁxed in 4% formaldehyde for 15 min at room tempera-
ture. Then the cells were permeabilized in 0.2% Triton X-100 and
blocked with 10% goat serum, then incubated with mouse mono-
clonal anti-phospho-Histone H2AX (Ser139) (cH2AX) for 1 h at
37 C in PBS with 10% goat serum and washed with PBS. The cells
were incubated with the Alexa 488 anti rabbit secondary antibody
for 1 h at 37 C in PBS with 10% goat serum and washed in PBS.
Cover glasses were mounted in ProLong Gold antifade reagent
with DAPI (Invitrogen). Fluorescence images were captured using
an Olympus DP70 ﬂuorescence microscope for analysis. All treat-
ment groups were then assessed for cH2AX foci via sequential44+/CD24+
44-/CD24-
CD44+/CD24+ CD44-/CD24-
Isotype control        CD44- CD44+                
Isotype control       CD24- CD24+                
-like cells. Colony and spheroid formation of CD44+/CD24+ and CD44/CD24 cells
presentative photos of positive cancer stem-like also displayed. ⁄p < 0.01, compared
Table 1
Tumor formation ability of sorted MIA PaCa-2 and BxPc-3 pancreatic cancer cells
using surface markers (number of tumors formed/number of injections).
Groups 2  104 1  104 5  103 3  103
MIA PaCa-2 3/4 2/3 2/3
CD44+/CD24+
MIA PaCa-2 2/4 1/3 0/0
CD44/CD24
p 0.001 0.001
BxPc-3 4/5 4/5 3/4 2/3
CD44+/CD24+
BxPc-3 3/5 2/5 1/4 0/0
CD44/CD24
p 0.001 0.001 0.001
p < 0.01 compared with results from marker-negative cells.
Table 2
RBE values at D10 level for unsorted and sorted cancer stem-like and non-cancer
stem-like cells.
Cells X-ray (Gy) C-ion (Gy) RBE
MIA PaCa-2 3.72 ± 0.20 2.01 ± 0.10 1.85
Unsorted
BxPc-3 4.24 ± 0.12 2.02 ± 0.07 2.10
Unsorted
MIA PaCa-2 4.26 ± 0.11 2.12 ± 0.10 2.01
CD44+/CD24+
MIA PaCa-2 2.83 ± 0.13 1.92 ± 0.07 1.47
CD44/CD24
BxPc-3 CD44+/CD24+ 4.64 ± 0.21 2.12 ± 0.09 2.19
260 Effects of heavy-ion irradiation on pancreatic cancer stem-like cellsimaging through each nucleus. A minimum of 100 cells in each
treatment group were counted. Nuclear cH2AX foci size was esti-
mated by ImageJ 1.45 software (NIH).Statistical analysis
One-way ANOVA and Bonferroni multiple comparison tests
were used when mean differences between the groups were eval-A X-ray cd44+/cd24+
C-ion cd44+/cd24+
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Fig. 2. Surviving fraction of unsorted, sorted cancer stem-like cells, and non cancer stem-
carbon ion irradiation. The graphs show the mean and standard error calculated from thr
spheroid formation of cancer stem-like cells and non cancer stem-like cells after irradiati
X-rays or carbon ion beams. The graphs show the mean and standard error calculated fuated by StatView software (SAS Institute, Inc., Cary, NC). For all
comparisons, p values less than 0.05 were deﬁned as signiﬁcant.
Results
Determination of cancer stem-like cell properties of CD44+/CD24+ cells
As shown in Fig. 1, CD44+/CD24+ cells had greater colony and
sphere formation abilities than CD44/CD24 cells. When equal
numbers of 500 cells were plated in a dish, CD44+/CD24+ cells from
MIA PaCa-2, BxPc-3 formed 112 ± 6, 26 ± 2 clones, whereas CD44/
CD24 cells formed only 40 ± 2, 2 ± 1 clones (p < 0.01). These data
showed that CD44+/CD24+ pancreatic cancer cells had much
greater clonal formation capacities than those of CD44/CD24
cells. To investigate the ability to form spheroid bodies, isolated
CD44+/CD24+ and CD44/CD24 cells were cultured in 96-well
plates precoated with a layer of 1% agarose. After being in culture
for 1 week, CD44+/CD24+ formed spheroid bodies (Fig. 1A and B).
The ability to form spheroid bodies in CD44+/CD24+ was signiﬁ-
cantly higher than that in CD44/CD24 (p < 0.01).
Aliquots of 3  103 CD44+/CD24+ cells isolated fromMIA PaCa-2
and BxPc-3 were transplanted subcutaneously into the right lower
thigh of immunodeﬁcient SCID mice and 3  103 CD44/CD24
cells were transplanted subcutaneously into the left lower thigh.
As shown in Table 1, the tumorigenicity of CD44+/CD24+ pancreatic
cancer cells was much higher than CD44/CD24 cells. Collec-
tively, our data suggested that CD44+/CD24+ cells isolated from
MIA PaCa-2 and BxPc-3 cells present the characteristics of cancer
stem-like cells.Surviving fraction of unsorted and sorted CD44+/CD24+ cells from MIA
PaCa-2 and BxPc-3 cells after carbon-ion beam or X-ray irradiation
The surviving fractions for the MIA PaCa-2 and BxPc-3 irradi-
ated with X-rays and carbon ions decreased exponentially with
increasing doses (Fig. 2A and B). Based on these survival curves,X-ray cd44+/cd24+
C-ion cd44+/cd24+
BxPc-3
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Fig. 2. (continued)
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dose (Gy) required to reduce the surviving fraction to 10%, relative
to X-rays, are about 1.85–2.10 for carbon-ion beams (Table 2). The
results show that the surviving fractions for cancer stem like
CD44+/CD24+ cells are signiﬁcantly higher than non-cancer stem
like CD44/CD24 cells after irradiation with either X-rays or car-
bon ion beams (Fig. 2A and B), suggesting that cancer stem-likecells showed resistance to both X-rays and carbon ions. The surviv-
ing fractions for the cancer stem like cells sorted from the 2 cell
lines after irradiation with X-rays and carbon ions decreased
exponentially with increasing doses. Based on these survival
curves, the RBE values calculated at the D10 level for cancer
stem-like cells were calculated to be about 2.0–2.19, whereas
RBE values for non-cancer stem-like cells were about 1.47. We
262 Effects of heavy-ion irradiation on pancreatic cancer stem-like cellscould not calculate the RBE of non-cancer stem-like cells from
BxPc-3, since there were too small a number of colonies formed
after carbon ion beam or X-ray irradiation. RBE values for unsorted
and sorted cancer stem-like and non-cancer stem-like cells of car-
bon ion beams relative to X-rays are summarized in Table 2. In
addition, we have also examined the tumor spheroid formation
ability of cancer stem-like cells and non cancer stem-like cells after
irradiation with X-rays or carbon ion beams. As shown in Fig. 2C,
the number of tumor spheroid formations is signiﬁcantly lower
in carbon ion irradiated cancer stem-like cells delivered from both
MIA PaCa-2 and BxPc-3 cells compared to that of X-ray irradiated
ones. In contrast, there are not any spheres formed in non cancer
stem-like cells with or without X-ray or carbon ion irradiation.Changes in proportion of CD44+/CD24+ cells after carbon-ion or X-ray
irradiation
The percentages of each CD44+ and CD24+ cells before irradia-
tion were 1.6%, 6.5% for BxPc-3 cells, and 49.9% and 3.4% for MIA
PaCa-2 cells, respectively. In MIA PaCa-2 and BxPc-3 cells, changes
in the percentages of CD44+/CD24+ cells 96 h after X-ray or carbon
ion irradiation were investigated. Based on the surviving curve in
Fig. 2, the RBE for both cell lines is about 2 (1.85–2.10), thus the
isoeffective doses which produce the same biological effects by
carbon ion beam are about half doses of X-ray. In MIA PaCa-2 cells,
CD44+/CD24+ cells increased to 1.6% or 3.0%, representing increases
of 3- to 6-fold, after X-ray irradiation at 2 or 4 Gy, respectively,
whereas increases by about 2-fold were observed after carbon
ion irradiation at both isoeffective doses of 1 or 2 Gy (Fig. 3A). In
BxPc-3, CD44+/CD24+ cells increased to 16.3% and 16.0%, represent-
ing increases of more than 3-fold, after X-ray irradiation at 2 or
4 Gy, respectively, whereas decreases to 3.2% or 2.8% were ob-
served after carbon ion irradiation at 1 or 2 Gy, respectively
(Fig. 3B). Since results of K-ras mutant MIA PaCa-2 cell line were0 Gy X-2 Gy
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Fig. 3. Percentage changes of CD44+/CD24+ and CD44/CD24 cells by FACS analysis 96 h
compared to non-IR cells.similar to K-ras wild type BxPc-3 cell line, there seems to be no
relationship between reduction of CD44+/CD24+ cells by carbon
ion irradiation and K-ras status.cH2AX foci formation in CD44+/CD24+ and CD44/CD24 cells after
carbon-ion or X-ray irradiation
A high number of cH2AX foci formed at 1 or 6 h after X-ray or car-
bon ion irradiation both in CD44+/CD24+ and CD44/CD24 cells
which had been sorted from MIA PaCa-2 (Fig. 4A, B,C, supp Fig. 1).
The same results were also obtained in CD44+/CD24+ and CD44/
CD24 cells which had been sorted from BxPc-3 (data not shown).
However, at 24 h after carbon ion irradiation, the induced cH2AX foci
level remained signiﬁcantly higher than that of X-ray irradiated cells
with isoeffectivedosages (Fig.4A,B, suppFig.2). Furthermore,a strong
increase in the size of foci (clustered DNA damage) was only found in
carbon ion beam irradiated cells (Fig. 4A, B, and C). Interestingly, the
big-sized cH2AX foci was observed more frequently in CD44+/CD24+
cells than in CD44/CD24 cells (Fig. 4C). In addition, the number of
cH2AX foci formed inCD44+/CD24+ cells decreasedmore signiﬁcantly
than in CD44/CD24 cells after X-ray irradiation (Fig. 4C), indicating
that CD44+/CD24+cells have an increased capacity to repair X-ray or
carbon ion-induced DSBs, which is likely to be a major contributor
to their relatively greater degree of radioresistance.
Discussion
We found that the in vitro RBE value, calculated by the D10
relative to the X-rays, is about 1.85–2.10 for the 50-keV/lm SOBP
carbon ion beam on MIA PaCa-2 or BxPc-3cells in this study. RBE
values are known to be dependent on LET, and our results are
partially in line with previous reports using carbon ion beams
on several human cancer cells, which reported 1.57–2.60 for
50–80 keV/lm-beams [18].C
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1 Gy of carbon ion beam. (B) Representative photos and quantiﬁcation of nuclear cH2AX foci formation at 24 h post-irradiation was presented according to radiation dose
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Quantiﬁcation of nuclear cH2AX foci size after 24 h X-ray or carbon ion beam irradiation. cH2AX foci sizes were presented according different radiation doses. ⁄p < 0.01
compared to cH2AX foci sizes in X-ray irradiated cells. CSC, cancer stem cell (CD44+/CD24+)
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are markers for identifying pancreatic cancer stem cells [5,6]. How-
ever, it has been demonstrated that different cell lines or tumor
types have different cancer stem cell markers, and CD133 is not al-ways expressed in tumorigenic cancer stem-like cells [19]. In the
present study, CD133 was not detected in both MIA PaCa-2 and
BxPc-3 cells, whereas ESA was only detected in BxPc-3 cells. There-
fore, we isolated and collected CD44+/CD24+ and CD44/CD24
264 Effects of heavy-ion irradiation on pancreatic cancer stem-like cellscells from MIA PaCa-2 and BxPc-3 cells. We found that CD44+/
CD24+ cells have a signiﬁcantly higher possibility for colony and
tumor sphere formation than CD44/CD24 cells. The in vivo
tumorigenicity study showed that the tumorigenicity of CD44+/
CD24+ pancreatic cancer cells is much higher than CD44/CD24
cells. CD44+/ESA+ cells sorted from BxPc-3 cells also showed cancer
stem-like cell properties compared to CD44/ESA cells (data not
shown).
In the present study, FACS analyses showed that the proportion
of cancer stem-like CD44+/CD24+ cells was more highly enriched
after X-rays compared to carbon ion irradiation. The percentages
of cancer stem cell-like CD44+/CD24+ cells increased markedly by
3- to 6-fold after X-ray irradiation, whereas the proportion of these
cells only doubled or decreased after carbon ion irradiation. It is
suggested that cancer stem cell-like CD44+/CD24+ cells may be
resistant to X-ray resulting in selective killing of non-cancer stem
cell-like CD44/CD24 cells leading to an increase in the relative
proportion of cancer stem cell-like cells, whereas carbon ion irradi-
ation may kill both cancer and non-cancer stem cell-like cells at
the same time, with relatively small changes in the proportion of
cancer stem cell-like cells in the population. This ﬁnding is consis-
tent with our and other previous reports [17]. To directly deter-
mine the radiosensitivity of pancreatic cancer stem-like CD44+/
CD24+ cells between carbon ion and X-ray irradiation, a colony as-
say was performed. Based on dose–response curves for cell-killing
effect on cancer stem like cells and non-cancer stem like cells after
irradiation with either X-rays or carbon ion beams, the cancer
stem-like cells showed resistance to both X-rays and carbon ions
compared to non-cancer stem-like cells, although in a previous re-
port no signiﬁcant radioresistance was found with another pancre-
atic cell lines and cancer stem-like cell markers [20]. The surviving
fractions for the cancer stem like cells after irradiation with X-rays
or carbon ions decreased exponentially with increasing doses, and
the RBE values calculated at the D10 level for cancer stem-like cells
delivered from MIA PaCa-2 and BxPc-3 were about 2.0–2.19, sug-
gesting that the carbon ion beam has a promising potential to de-
stroy cancer stem-like cells. In contrast, RBE values at the D10 level
for non-cancer stem-like cells delivered from MIA PaCa-2 were
only 1.47, implying that the difference in killing pancreatic cancer
cells between carbon ion beam and X-ray irradiation might mainly
result from the strong effects on cancer stem-like cells. Taken to-
gether, these results can explain why a proportion of cancer
stem-like cells after irradiation with X-rays is more enriched than
carbon ion beams.
It has been reported that the radiation sensitivity of several cell
lines is closely related to the number of residual cH2AX foci which
refer to unrepaired DSBs [21]. Grosser et al. reported that high LET
iron ion radiation-induced cH2AX foci persisted for at least 72 h. In
comparison, the foci induced by c-rays disappeared after 22 h in
non-proliferating cells [22]. This is considered to be due to the
higher complexity of DSBs compared to low LET radiation. It has
also been shown that a LET dependency for the disappearance of
cH2AX clusters in normal human ﬁbroblasts between iron
(176 kev/lm) and silicon (54 keV/lm) ions, which is that iron ions
showed signiﬁcantly higher residual foci numbers compared to sil-
icon ions [23]. The number of cH2AX foci formed in cancer stem-
like cells decreased more signiﬁcantly than in non- cancer stem-
like cells after X-ray irradiation, suggesting that cancer stem-like
cell have an increased capacity to repair X-ray induced DSB. This
is in line with previous reports even using other pancreatic cell
lines and cancer stem-like cell markers [20]. The present study is
the ﬁrst to show quantitatively, the time course of the cH2AX-
immunoﬂuorescence intensity in pancreatic cancer stem-like cells
induced by a carbon ion beam and X-ray irradiation. Regarding car-
bon ion beam and X-ray irradiations, no signiﬁcant increase in thenumber of foci was found at 1 and 6 h post-irradiation. Conversely,
both X-ray and carbon ion beam dose-dependently induced an in-
crease in the number of cH2AX foci after 24 h irradiation, but car-
bon ion beam induced a larger number and size of cH2AX foci
compared to X-ray at the isoeffective doses. Although cH2AX, as
a residual DSB marker, has been reported to be unpredictable for
clonogenic cell survival depending on cell types or characters
[24], our immunostained nuclear histone cH2AX data are well in
line with surviving fraction [25] particularly for pancreatic cancer
stem-like cells (except non cancer stem-like cells delivered from
BxPc-3), indicating that radiosensitivity for putative pancreatic
cancer stem cells by carbon ion beam is higher than X-ray. An
explanation for this ﬁnding could be the high complexity of such
carbon ion-induced DSB, which results in a retardation of DSB
rejoining [12,13,22,23]. It is known that the high complexity of
these DSBs is a factor in the choice of repair pathway and homol-
ogous recombination is recruited in the repair of breaks with high-
er complexity during the late S and G2 phases of the cell cycle [13].
These results reveal the greater complexity of DSBs induced by
high LET radiation, which potentially leads to increased mutage-
nicity and decreased repairability of the damaged site. In addition,
it has also been demonstrated that mitotic cell death rather than
apoptotic cell death, as well as prolonged G2/M cell cycle arrest
induced by heavy ion beams are closely correlated with nonrepair-
able or slowly repaired DSBs [16]. Taken together, our results are
consistent with previous reports, which showed that variations
in the rate of dephosphorylation and the number of residual foci
are dependent on radiation quality, and also indicate that the
predominant effects of carbon ion beams on tumor cell killing
mainly result from efﬁcient eradication of cancer stem-like cells
rather than non-cancer stem-like cells.
In summary, the carbon ion beam has promising possibility for
targeting putative pancreatic cancer stem cells because of
prolonged DNA damage and subsequent cell death. Collectively,
our ﬁndings show the potential beneﬁts of utilizing a carbon ion
beam for targeting conventional X-ray radioresistant pancreatic
cancer stem-like cells.
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